Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease

NCT02405598 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Pompe Disease

Interventions

DRUG: Salbutamol

Sponsor

National Taiwan University Hospital